Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Bank of New York Mellon Corp
> NTLA
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Intellia Therapeutics, Inc. | NTLA | 399,046 | 31,108 | 16,273,076,000 | 2,560,044,000 | $40,779.95 |
| 03/31/2023 | Intellia Therapeutics, Inc. | NTLA | 367,938 | -10,812 | 13,713,032,000 | 498,460,000 | $37,269.95 |
| 12/31/2022 | Intellia Therapeutics, Inc. | NTLA | 378,750 | 378,750 | 13,214,572,000 | 13,214,572,000 | $34,889.96 |
| 09/30/2022 | Intellia Therapeutics, Inc. | NTLA | 0 | -299,739 | 0 | -15,514,000 | |
| 06/30/2022 | Intellia Therapeutics, Inc. | NTLA | 299,739 | 5,168 | 15,514,000 | -5,893,000 | $51.76 |
| 03/31/2022 | Intellia Therapeutics, Inc. | NTLA | 294,571 | -1,148 | 21,407,000 | -13,560,000 | $72.67 |
| 12/31/2021 | Intellia Therapeutics, Inc. | NTLA | 295,719 | -3,226 | 34,967,000 | -5,136,000 | $118.24 |
| 09/30/2021 | Intellia Therapeutics, Inc. | NTLA | 298,945 | 35,830 | 40,103,000 | -2,496,000 | $134.15 |
| 06/30/2021 | Intellia Therapeutics, Inc. | NTLA | 263,115 | 58,439 | 42,599,000 | 31,464,000 | $161.90 |
| 03/31/2021 | Intellia Therapeutics, Inc. | NTLA | 0 | -204,676 | 0 | -11,135,000 | |
| 12/31/2020 | Intellia Therapeutics, Inc. | NTLA | 204,676 | 16,707 | 11,135,000 | 7,398,000 | $54.40 |
| 09/30/2020 | Intellia Therapeutics, Inc. | NTLA | 187,969 | 1,360 | 3,737,000 | -186,000 | $19.88 |
| 06/30/2020 | Intellia Therapeutics, Inc. | NTLA | 186,609 | 13,643 | 3,923,000 | 1,808,000 | $21.02 |
| 03/31/2020 | Intellia Therapeutics, Inc. | NTLA | 172,966 | -51,001 | 2,115,000 | -1,171,000 | $12.23 |
| 12/31/2019 | Intellia Therapeutics, Inc. | NTLA | 223,967 | 9,365 | 3,286,000 | 421,000 | $14.67 |
| 09/30/2019 | Intellia Therapeutics, Inc. | NTLA | 214,602 | 66,470 | 2,865,000 | 440,000 | $13.35 |
| 06/30/2019 | Intellia Therapeutics, Inc. | NTLA | 148,132 | 22,386 | 2,425,000 | 277,000 | $16.37 |
| 03/31/2019 | Intellia Therapeutics, Inc. | NTLA | 125,746 | 2,895 | 2,148,000 | 471,000 | $17.08 |
| 12/31/2018 | Intellia Therapeutics, Inc. | NTLA | 122,851 | -8,200 | 1,677,000 | -2,074,000 | $13.65 |
| 09/30/2018 | Intellia Therapeutics, Inc. | NTLA | 131,051 | 7,557 | 3,751,000 | 372,000 | $28.62 |
| 06/30/2018 | Intellia Therapeutics, Inc. | NTLA | 123,494 | 44,015 | 3,379,000 | 1,703,000 | $27.36 |
| 03/31/2018 | Intellia Therapeutics, Inc. | NTLA | 79,479 | 6,155 | 1,676,000 | 267,000 | $21.09 |
| 12/31/2017 | Intellia Therapeutics, Inc. | NTLA | 73,324 | -415 | 1,409,000 | -423,000 | $19.22 |
| 09/30/2017 | Intellia Therapeutics, Inc. | NTLA | 73,739 | 18,937 | 1,832,000 | 956,000 | $24.84 |
| 06/30/2017 | Intellia Therapeutics, Inc. | NTLA | 54,802 | 23,126 | 876,000 | 430,000 | $15.98 |
| 03/31/2017 | Intellia Therapeutics, Inc. | NTLA | 31,676 | 1,682 | 446,000 | 52,000 | $14.08 |
| 12/31/2016 | Intellia Therapeutics, Inc. | NTLA | 29,994 | 9,403 | 394,000 | 43,000 | $13.14 |
| 09/30/2016 | Intellia Therapeutics, Inc. | NTLA | 20,591 | 20,591 | 351,000 | 351,000 | $17.05 |
| 06/30/2016 | Intellia Therapeutics, Inc. | NTLA | 21,626 | 21,626 | 462,000 | 462,000 | $21.36 |
| << Prev Next >> |
|